COMPUMEDICS LIMITED — Regulatory Filings 2009

Jun 2, 2009

==> picture [76 x 80] intentionally omitted <==

ASX / MEDIA RELEASE

Powerhouse Award Boosts Compumedics’ export drive

Melbourne Australia Wednesday, 3 June, 2009

Leading medical devices company, Compumedics Limited (ASX:CMP) today announced it has been awarded the Powerhouse Museum Award 2009 for design excellence and innovative use of technologies for Grael[TM] – the latest Sleep and Neurology recording system from Compumedics. The award adds further momentum to the Company’s export drive.

Compumedics’ Grael[TM] , is the world’s first High Definition PSG/EEG (polysomnography/ electroencephalography) recording system and will be an important component of the Company’s recently announced growth plans for the Company’s sleep diagnostics business in Europe. Compumedics recently announced the securing of a major sale in Germany following the Company’s decision to sell directly into Germany. The Grael[TM] EEG/PSG recording system will further underpin our growth ambitions in Europe by enabling the Company to substantially strengthen its distributor base across the region.

Further, Compumedics’ Grael[TM] will make its USA debut at the largest annual American sleep trade show, the Associated Professional Sleep Societies (APSS) meeting this weekend in Seattle, Washington. Grael[TM] will further underpin Compumedics’ growth ambitions for its sleep-diagnostics business in the USA, a market valued at over USD111 million and which demands quality, technical innovation, and reliability so Compumedics is a natural vendor of choice.

The Powerhouse Museum, through its support of excellence in Australian design and innovation makes an annual selection of products from the finalists in the Australian International Design Awards, and then awards one superior winner. The recipients of the Powerhouse Museum Design Award have demonstrated excellence in design and innovative use of new technologies to provide significant benefits to users. The technologies must also show potential to become important in the lives of Australians, be significant to Australian industry or provide an opportunity for Australian design to be recognised in the global marketplace.

Powerhouse Museum Curator of Product Design, Erika Dicker said, ”The Grael[TM] received the Powerhouse Museum Design Award for its smart and streamlined design, which integrates innovation, sustainability, and user awareness. It is an Australian product that has the potential to make a significant impact to the quality of health and wellbeing for those suffering sleep disorders."

The Grael[TM] PSG sleep diagnostic device will be on display in the “Success and Innovation” gallery at the Powerhouse Museum in Sydney.

Compumedics Limited (ASX:CMP)

Released on 3 June, 2009 Page 1 of 2

For Further information:

Mr David Burton Executive Chairman, CEO Phone: + 61 3 8420 7300 Fax: +61 3 8420 7399

Mr David Lawson Chief Financial Officer Phone: + 61 3 8420 7300 Fax: +61 3 8420 7399

Investor Relations & Media Enquires:

Mr Rod North Executive Director Bourse Communications Pty Ltd Phone: +61 3 9510 8309 Mobile: +61 (0) 408 670 706

About Compumedics

Compumedics Limited, founded in 1987, is a global leader in the design and manufacture of diagnostic technologies for sleep disorders, neurophysiology and cardiology. In 1987 Compumedics established Asia Pacific’s first fully computerised sleep laboratory. Compumedics holds 80% share of the Australian sleep-diagnostic market, and has a major and rapidly growing presence in the US, European and Asian marketplaces for its sleep, neurological, and Doppler blood-flow diagnostic monitoring devices. In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 14,000 studies with 20,000 patients scheduled by 2008. With headquarters in Melbourne, Australia and offices in the United States, and Europe the products are distributed in over 50 countries. In 1998 Compumedics was awarded the overall Australian Exporter of the Year. In 2000 Compumedics was listed on the Australian Stock Exchange. In 2002 , Compumedics acquired US-based Neuroscan - the world's leading supplier of instruments for brain-research. In the US - the world's largest medical device market - Neuroscan holds around 90% of the market for brain-research products. In 2003 Compumedics was awarded the Frost & Sullivan Award for Market Expansion Strategy. In 2004 , Compumedics acquired German-based DWL Elektronishe GmbH, enabling Compumedics to expand its global operations into the neurovascular and cardio-vascular diagnostic fields. In 2006 , Compumedics was awarded the Frost and Sullivan Technology Leadership award for the innovative Somté recorder product. In 2007 , Compumedics and Chairman were inducted into the Victorian Manufacturing Hall of Fame. In 2008 the DWL division received the top 100 German Innovation award. With 20,000 systems installed globally across the finest hospital, universities and clinics the Compumedics sales have grown more than 4 fold from $9 million (1999) to $39 million (2008). www.compumedics.com

Compumedics Limited (ASX:CMP)

Released on 3 June, 2009 Page 2 of 2